Faruqi & Faruqi, LLP Announces the Investigation of Health Net Inc. (HNT) Over the Proposed Sale of the Company to Centene Corp.
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Health Net Inc. (“Health Net” or the “Company”) (NYSE:HNT) for potential breaches of fiduciary duties in connection with the sale of the Company to Centene Corp. for approximately $6.3 billion in a cash-and-stock deal.
The Company’s stockholders will only receive 0.622 shares of Centene and $28.25 in cash for each Company share held, for a total consideration of $78.57 based on Wednesday’s closing price. However, at least one analyst’s target price is set at $75.00 and the share price of the Company is expected to continue climbing.
The investigation focuses on whether Health Net’s Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct a fair sales process and whether and by how much this proposed transaction undervalues the Company to the detriment of Health Net’s shareholders.
Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.
* The submission of this form does not create an attorney-client relationship.
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.